- Home
- CTNM vs CTO Comparison
CTNM vs CTO Comparison
Compare CTNM & CTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CTNM | CTO |
|---|---|---|
| Founded | 2009 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Real Estate Investment Trusts |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 575.3M | 586.6M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | CTNM | CTO |
|---|---|---|
| Price | $13.77 | $19.75 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | $18.60 | ★ $21.50 |
| AVG Volume (30 Days) | 188.4K | ★ 255.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.75% |
| EPS Growth | ★ 0.46 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $7.63 |
| Revenue Next Year | N/A | $2.76 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.35 | $15.07 |
| 52 Week High | $16.33 | $20.25 |
Technical Indicators
Market Signals| Indicator | CTNM | CTO |
|---|---|---|
| Relative Strength Index (RSI) | 43.77 | 64.94 |
| Support Level | $10.17 | $17.29 |
| Resistance Level | $16.17 | $20.25 |
| Average True Range (ATR) | 0.99 | 0.42 |
| MACD | -0.32 | 0.01 |
| Stochastic Oscillator | 17.57 | 65.40 |
Price Performance
Historical ComparisonAbout CTNM Contineum Therapeutics Inc.
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
About CTO CTO Realty Growth Inc.
CTO Realty Growth Inc is a real estate investment trust company, that owns income properties comprised of approximately 2.7 million square feet in diversified markets in the United States. Its portfolio of assets consists of Income Properties Portfolio, management services, Commercial Loan and Investments.